Moderna's Plans for Another COVID Campaign in April 2025

The text discusses Moderna's plans for another COVID campaign starting in April 2025, including the company's focus on driving COVID-19 and RSV vaccine sales despite challenges in the market. There are also insights into the company's R&D pipeline, the expectation of increased COVID vaccine production in 2024, and speculations about the timing of these plans in relation to the 2024 election year. Additionally, the text touches on Moderna's relationship with the government, its production methods, and predictions about dominant narratives in the upcoming election year.